BUSSE; Madleen
Patent Applications and Registrations
Patent applications and USPTO patent grants for BUSSE; Madleen.The latest application filed is for "novel heavy metal ion-ligand-complexes useful as ex vivo contrast agent for a computed tomography scanning of a biological sample, ex vivo method for investigating a biological sample, and use of the complexes".
- BUSSE; Madleen - Eching DE
| Patent | Date |
|---|---|
| Novel Heavy Metal Ion-ligand-complexes Useful As Ex Vivo Contrast Agent For A Computed Tomography Scanning Of A Biological Sample, Ex Vivo Method For Investigating A Biological Sample, And Use Of The Complexes App 20210371436 - BUSSE; Madleen ; et al. | 2021-12-02 |
| Novel Heavy Metal Ion-hematein-complexes Useful As Ex Vivo Contrast Agent For A Computed Tomography Scanning Of A Biological Sam App 20200271554 - BUSSE; Madleen ; et al. | 2020-08-27 |
| Antibacterial bismuth complexes Grant 10,501,487 - Andrews , et al. Dec | 2019-12-10 |
| Antibacterial Bismuth Complexes App 20180155378 - Andrews; Philip ; et al. | 2018-06-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 